Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on October 5, 2026

8 hours ago

Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026

Indeterminate GlobeNewswire

8 hours ago

Kymanox Launches KymaBridge, an Intelligence Platform Connecting Pharma and Biotech Innovators with Drug Delivery Device Technologies

Indeterminate GlobeNewswire

8 hours ago

Beacon Therapeutics Named a “Fierce 15” Company by Fierce Biotech

Indeterminate GlobeNewswire

8 hours ago

Curia Invests $28 Million in Sterile API Manufacturing

Indeterminate GlobeNewswire

8 hours ago

Curia investiert 28 Mio. USD in die Herstellung steriler Wirkstoffe

Indeterminate GlobeNewswire

8 hours ago

Curia invierte $28 millones en la fabricación de API estériles

Indeterminate GlobeNewswire

8 hours ago

Curia investit 28 millions de dollars dans la fabrication d’API stériles

Indeterminate GlobeNewswire

8 hours ago

קוריה משקיעה 28 מיליון דולר בייצור רכיבים פעילים (API) סטריליים

Indeterminate GlobeNewswire

8 hours ago

Curia Berinvestasi $28 Juta untuk Manufaktur API Steril

Indeterminate GlobeNewswire

8 hours ago

キュリア、無菌API製造に2800万ドル (約44億円) を投資

Indeterminate GlobeNewswire

8 hours ago

Curia, 무균 API 생산에 2,800만 달러 투자

Indeterminate GlobeNewswire

8 hours ago

Curia Melabur AS$28 Juta dalam Pengeluaran API Steril

Indeterminate GlobeNewswire

8 hours ago

Curia Investe US$ 28 Milhões na Fabricação de IFAs Estéreis

Indeterminate GlobeNewswire

8 hours ago

Curia ลงทุน 28 ล้านดอลลาร์สหรัฐฯ ในการผลิตสารออกฤทธิ์ทางเภสัชกรรม (Active Pharmaceutical Ingredient: API) ปลอดเชื้อ

Indeterminate GlobeNewswire

8 hours ago

Curia 投资 2,800 万美元扩大无菌原料药产能

Indeterminate GlobeNewswire

8 hours ago

Curia 投資 2,800 萬美元於無菌有效藥劑成分製造

Indeterminate GlobeNewswire

8 hours ago

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

Indeterminate GlobeNewswire

8 hours ago

Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026

Indeterminate GlobeNewswire

8 hours ago

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Indeterminate GlobeNewswire

8 hours ago

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire